Treatment of bipolar I disorder in an adolescent with olanzapine.
Publication/Presentation Date
1-1-2000
Abstract
Bipolar I disorder is estimated to affect 0.6% of adolescents. Lithium, sodium valproate, carbamazapine, and adjunctive treatment with benzodiazapines and antipsychotics have been used to treat bipolar I disorders. We report a case of a 17-year-old adolescent male with bipolar I disorder who responded favorably to the treatment with the atypical antipsychotic olanzapine. We hypothesize that olanzapine's broad affinity for both dopaminergic and serotonergic receptors may be related to the beneficial therapeutic outcome.
Volume
10
Issue
2
First Page
147
Last Page
151
ISSN
1044-5463
Published In/Presented At
Khouzam, H. R., & El-Gabalawi, F. (2000). Treatment of bipolar I disorder in an adolescent with olanzapine. Journal of child and adolescent psychopharmacology, 10(2), 147–151. https://doi.org/10.1089/cap.2000.10.147
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
10933124
Department(s)
Administration and Leadership
Document Type
Article